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ABSTRACT
The prevalence of lifestyle disorders such as hypertension, diabetes mellitus (DM), dyslipidemia, and overweight/obesity is rising rapidly. Recently 
the popularity of herbal supplements among patients with lifestyle disorders has been increasing. Consumption of a plant-based diet consisted of 
appropriate phytochemicals has been accepted as a reliable means for the prevention and management of several disorders. Phytochemicals play a 
crucial role in disease prevention, especially when lifestyle changes alone are not found effective. Various human and animal trials have established 
the pharmacological action of phytonutrients present in herbal plants. Several bioactive compounds such as polyphenols, flavonoids, alkaloids, and 
stilbenes. are present in plants such as garlic, Aloe vera, turmeric, tulsi, and drumstick. that have shown a significant beneficial effect on DM, metabolic 
syndrome, lipid disorders, etc. This review focuses on the therapeutic effect of some of the high potential herbal plants and their phytochemicals in 
the management of lifestyle disorders and the challenges with the use of herbal medicines.
Keywords: Type 2 diabetes mellitus, Lifestyle disorders, Pharmacological studies, Phytochemicals, Herbal drug targets, Adenosine monophosphate-
activated protein kinase.
INTRODUCTION
India has a long history and strong base for the traditional system of 
medicine. Herbal plants play an important role in the prevention and 
treatment of human diseases for decades. It is well established that 
herbal plants are a rich source of phytochemical moieties (primary 
and secondary metabolites), which serve as the principle element for 
the medicinal value of these herbs. In recent years, there has been a 
resurgence of interest to rediscover medicinal plants as potential drug 
candidates. There have emerged new insights in the field of herbal 
medicine and these drugs are gaining increasing acceptance in both 
developing as well as developed countries due to their natural origin 
and relatively fewer side effects. Nature has been a source of therapeutic 
agents for thousands of years, and a large number of modern important 
medications have originally been obtained from natural sources 
(for example, vincristine from Vinca rosea, morphine from Papaver 
somniferum, Taxol from Taxus brevifolia, Atropine from Atropa 
belladonna, etc.) [1]. Currently, the revival of interest in natural products 
as a potential hotspot for new solutions has gained the attention of the 
academicians and pharmaceutical industry. A large number of plants 
with the traditional claim of antidiabetic, antioxidative, and anti-
inflammatory activities have been studied worldwide and their efficacy 
has been validated.
HERBAL PLANTS IN LIFESTYLE DISORDERS
In the Indian traditional system of medicine around 20,000 herbal 
(medicinal) plants have been documented; though only around 
7000–7500 plants are being used to cure different diseases. Moreover, 
the proportion of these plants in Ayurveda, Siddha, and Unani systems 
is around 2000, 1300, and 1000 respectively. Besides, around 25,000 
plant-based formulations are currently in use in Indian traditional 
systems. Lifestyle disorders are non-communicable diseases and are 
associated with a sedentary lifestyle, unhealthy food habits, substance 
abuse like alcohol, smoking habits, etc. Obesity is one of the global 
epidemics and over the years it has come up as a social issue as it 
leads to several health risks. Obesity is one of the leading causes of the 
development of metabolic disorders such as diabetes, hypertension, 
and cardiovascular diseases. As per the estimate of the International 
Diabetes Federation, 25% of the global adult population has metabolic 
syndrome and its prevalence is predicted to increase in the next few 
decades [2]. Diabetes mellitus (DM) is a lifestyle disorder characterized 
by chronic hyperglycemia which is accompanied by increased production 
of free radicals or oxidative stress which leads to inflammation and 
several microvascular and macrovascular complications. Herbal 
plants are rich sources of flavonoids and polyphenolic compounds 
that show antioxidant activities. In the present review, we summarize 
the role of herbal plants and their phytochemicals in the prevention 
and management of lifestyle disorders. The therapeutic efficacy of 
herbal plants in lifestyle disorders has been summarized in Table 1. 
The traditional systems of medicine have gained acceptance by the 
vast population due to relatively fewer side effects and these play a 
crucial role in the overall health care system especially in developing 
countries. The demand for herbal-based medicine, health products, 
pharmaceuticals, food supplements, nutraceuticals, cosmetics is 
continuously increasing worldwide.
PHYTOCHEMICALS AND THEIR THERAPEUTIC EFFICACY IN 
LIFESTYLE DISORDERS
Herbal plants contain several bioactive metabolites whose additive 
and synergistic therapeutic efficacy is beneficial in the prevention 
and management of lifestyle disorders [42]. Phytochemicals are the 
primary and secondary metabolites of herbal plants and are essential 
for the protection and survival of plants. It is well established that the 
phytochemicals extracted from plants have therapeutic efficacy for 
the prevention and management of many disorders. Polypotenoids, 
flavonoids, coumarins, indoles, isoflavones, lignans, organosulfurs, 
catechinsthe, phenolic acids, stilbenoids, isothiocyanates, saponins, 
procyanidins, phenylpropanoids, anthraquinones, ginsenosides are 
the major classes of phytochemicals present in various herbal plants. 
The phytochemicals and their pharmacological activities in lifestyle 
disorders have been summarized in Table 2.
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Table 1: Therapeutic efficacy of herbals plants in lifestyle disorders
Plant species  
(common Name)
Part Used Pharmacological activity Active agent (s) References
Allium sativu (Garlic) Bulbs Hypoglycemic, hypolipidemic; 
cardioprotective, anti-inflammatory
Allicin, Terpenoids, flavonoids, 
and phenols
[3]
Aloe vera (Gheekumari) Allium 
cepa Linn Onions
Leaves Bulbs Antidiabetic, Hepatoprotective, 
and reduces obesity-induced 
Glucose intolerance, Hypoglycemic, 
hypolipidemic; Reduces proteinuria, 
Cardioprotective, anti-inflammatory, 
Anti-bacteria and also prevents high 
blood pressure
Aloin and emodin, campesterol, 











Inhibitor of carcinoma, 
chemopreventive, inhibit colon 
cancer, antiallergic, Blood purifier, 
Anti malaria, insecticide
Aristolochic
Acids, aristolachine, aris tannic 
acids, aristidinic acids
Limonoids (nimbidinin), 
Di- and tri terpenoids, Quinine
[6,7]
Berberis vulgaris (Barberry)
Cannabis sativa L. (Marijuana)




Psychoactive rapid and long-lasting 
downregulation of CB1R causes 





Capsicum annum (Bell pepper) Fruits, and Leaves Prevention of heart attack and 
stroke
Capsaicin, Capsaicinoids [10]
Carpobrotus edulis (L.) (ice 
plant)





Whole, Plants (leaf, 
root, and stem)
Hypoglycemic; hypolipidemic; 
Increases the activity of glycolytic, 
Pathway enzymes
Alkaloid [12]
Cichorium intybus (chicory) Leaves, roots Anti-hyperglycemic, 
antilipidemic, anti-oxidative, and 
anti-inflammatory activities
Alkaloids, flavonoids, tannin, s 
and Cichoric acid
[11,12]
Coix lacryma‑jobi L. (Adlay) Seeds Downregulation of adipogenesis, 
anti-obesity
Flavonoid, steroids, and 
Carotenoïds
[13]
Cucumis africanus L. (Scarlet 
gourd)
Whole plant Weight loss Flavonoids [14]
Curcuma longa (Haldi) Rhizome Anti-inflammatory, 
hepatoprotective, and antioxidant 
effects
Flavonoid (Curcumin) [15]








Essential oils (e.g. Citral), 
Limonine,
Camphene, citronella, Geraniol, 
Alkaloids
[16,17]
Digitalis lanata (Tilapushpi) Leaves Used in heart diseases. Digoxin [18]
Foeniculum vulgare (Mill 
Fennel)
Seeds Reduces oxidative stress, decrease 
fat and sugar absorption
Phytoestrogens, Dipentene [19]











Africana (L.) (Baboonts 
Cucumber)
Tuber Α-amylase, α-glucosidase, and 
Lipase inhibitory activities
Luteolin and Kaempferol [22]
Mangifera indica (Mango) Stem bark, Leaves, 
fruit
Mangiferin Mangiferin [23]
Moringa oleifera (Drum stick) Leaves, Seeds Antioxidants, lowers body weight, 





Momordica charantia (Karela) Fruit Antidiabetic, antioxidant Momordicin, charantin [25]
Nigella sativa (Black cumin) Seeds Antidiabetic, hepato renal protective Thymoquinone [26]









Ocimum sanctum (Tulsi) Whole plant Antidiabetic, hepatoprotective Apigenin, taxol, and ursolic acid [28]
Phyllanthus emblica (Amla) Fruit Hepatoprotective, antioxidative, and 
anti-diabetic
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A wide range of chemical compounds is synthesized by plants, which 
are classified based on their chemical nature, biosynthetic origin, and 
functional groups into primary and secondary metabolites. Secondary 
metabolites have a wide range of medicinal properties and are the basic 
source for several current allopathic drugs also [66]. Alkaloids, tannins, 
flavonoids, saponin, and glycosides are the important secondary 
metabolites present in plants. Polyphenols and flavonoids are the 
families of phytochemicals known for their health benefits due to their 
antioxidative and anti-inflammatory effects [67]. Lifestyle disorders 
are characterized by inflammati on and an increased level of oxidative 
stress [68]. Hence, intake of antioxidants in the diet could have 
positive effects on lifestyle disorders such as obesity, Type 2 DM, etc. 
Polyphenols are grouped into different classes as per their structure: 
(i) Simple phenolic acid, for example., ferulic, gallic, ellagic, cholorogenic 
acid, etc., (ii) curcuminoids, for example., curcumin, (iii) stilbenes e.g. 
Resveratrol, (iv) lignans, for example., matairesinol, (v) chalcones, for 
example. phlorizin, chalcone and (vi) flavonoids. The flavonoids are 
further classified in different subclasses: (a) Flavonols e.g. quercetin, 
proanthocynidins, (b) anthocyanins, (c) flavanonols, for example. 
taxifolin, (d) flavanones, for example. naringenin, and (e) isoflavones, e.g. 
genistein. As discussed earlier, DM is significantly associated with several 
macro and microvascular complications. These complications are due 
to chronically elevated hyperglycemia and subsequent oxidative stress. 
Moreover, a mechanism that contributes to the elevation of oxidative 
stress in diabetic patients includes nonenzymatic glycosylation, auto-
oxidation of glucose, and metabolic stress and may partially be reduced 
by antioxidants [69]. The phenolic content of plants could be used as 
the basis for rapid screening of antioxidant activity due to the presence 
of hydroxyl group which provides free radical scavenging ability. The 
antioxidant activity of flavonoids which include flavones, flavanols 
and condensed tannin depends on the free -OH group, especially 
3-OH. Resveratrol is present in various plants and has a plethora of 
therapeutic efficacy including anti-inflammatory and antioxidant [70]. 
It regulates cellular energy metabolism and mitochondrial homeostasis 
by targeting sirtuin 1 and (AMPK) [71]. Luteolin (flavones) imparts its 
anti-inflammatory activity by the inhibition of nuclear factor kappa 
B gene expression [72]. The phytochemicals present in herbal plants 
have anti-obesity activities; these suppress the growth of adipocytes, 
inhibit preadipocyte differentiation and stimulate lipolysis. Genistein 
suppresses preadipocyte proliferation and adipogenic differentiation 
of adipose tissue by the instigation of Wnt signaling via ERs-dependent 
pathways such as Erk/JNK signaling and lymphoid enhancer factor/T 
cell factor (LEF/TCF4) co-activators [72]. Organosulfurs are widely 
distributed in several herbal plants and the phytochemicals under this 
group exert antilipidemic activities through inhibition of 3-hydroxy-
3-methyl-glutaryl-coenzyme A reductase. These also lower blood 
pressure and have antithrombotic and hypoglycemic efficacy [73]. 
The sesquiterpene (terpenoid) has shown beneficial effects in the 
management of diabetes and obesity-related inflammation [74]. 
Diosgenin, campesterol, brassicasterol, sitosterol, stigmasterol, and 
guggulsterone phytochemicals are grouped under the phytosterols and 
have efficacy in the management of obesity and decrease serum total 
and low-density lipoprotein-cholesterol levels [75].
CHALLENGES IN THE USE OF HERBAL MEDICINES
In recent years, a belief of the general public towards herbal medicines 
had is significantly increased due to several factors as follows: 
(a) Promotion of the traditional systems and herbal medicines by the 
government and other agencies, (b) several claims on the efficacy of 
herbal medicines and their wide advertisement in mass media, (c) 
preference of consumers for herbal therapies as it is generally believed 
that these are less toxic as compared to synthetic drugs, (d) discontent 
with the results from pharmaceutical molecules and synthetic drugs 
and increasing acceptance in the efficacy of herbal medicines in the 
treatment, (e) pharmaceutical drugs have a relatively higher cost 
and more side effects, (f) inferential approach based on subjective 
information, that is, “it worked for my family”) treatment based on 
the faith rather than scientific information. Although the use of herbal 
medicines has both benefits and risks, it provides an alternative and 
Plant species  
(common Name)
Part Used Pharmacological activity Active agent (s) References





Antiparasitic, Antimicrobial and 
antifungal activities










Leaves, Seeds Antihypertensive Reserpine, Deserpidine, 
Rescinamine, Yohimbine
[32]
Ricinus communis (Castor bean) Leaf, root, and seed Hepatoprotective, anti-oxidant, 
Hypoglycemic
Alkaloid (ricinine), lectin (ricin) [33]
Silybum marianum (Milk 
thistle)
Fruits, seeds, and 
leaves
Anti-inflammatory, liver tonic for 
hepatic disorders
Flavonoid silymarin (Silibinin) [34]
Swertia chirata (Chirayita) Whole plant Antidiabetic effect, antiviral, 
Hepato-renal protective
Ophelic acid, sawertiamarine, 
Mangeferin and amarogenitine
[35]
Syzygium cumini (Jamun) Seed, bark Antidiabetic Anthocynins, polyphenols [36]
Terminalia chebula (Harra) Fruits, Bark Anti-oxidant, anti-diabetic, 
Renoprotective, hepatoprotective




Terminalia arjuna (Arjuna) Stem-bark Cardioprotective, hepatoprotective Arjunic acid, tannic acid, 
tannins, saponins, gallic acid 
and phytosterols
[38]






Seeds, leaves Antidiabetic Fenugreekine, nicotinic acid, 
phytic acid, scopoletin and 
trigonelline
[40]
Zingiber officinalis (Ginger) Rhizome Antioxidant, Hepatoprotective, 
hypercholesterolaemic
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effective treatment for many disorders. However, there is a lack of 
safety studies on herbal medicines. We strongly advocate the following 
issues for the use of herbal medicines as follows: (i) Quality certification 
is strictly required for herbal products that include authentication, 
standardization, and stability of the product. (ii) Safety of the herbal 
product: The consumers erroneously recognize that as the herbal 
medicines are natural so these are safe, which is not always true. (iii) 
Pharmacokinetic profile: The efficacy of any drug depends on the 
optimum dose. Hence, the selection of key metabolite(s) and their 
pharmacokinetic profile is essential. (iv) Efficacy of herbal products: 
A well-planned, scientifically designed preclinical and clinical study is 
crucial for the efficacy of herbal products. Hence, a pertinent regulatory 
system is required to take suitable measures for ensuring the quality 
of herbal medicines in respect to safety, efficacy, uniformity, and other 
factors of the herbal products.
CONCLUSION
Similar to conventional synthetic medicines, there needs to be a 
licensing system for herbal medicine based on safety, quality, and 
Table 2: Summary of potential phytochemicals present in several herbal plants and their pharmacological activities





Capsaicin 8-methyl-N-vanillyl-6-nonenamide Weight-loss, attenuate obesity-related, 
metabolic disorders and liver diseases, 
enhances adiponectin levels
[43]
Carotenoids Lipophilic pigments tetraterpenoids Powerful antioxidant agents [44]
Catechins Derivatives of flavans, possess a 
2-phenyl-3,4-dihydro-2H-chromen-3-ol 
skeleton
Inhibit gastric lipases and increase 
thermogenesis
[45]
Chalcones Open-chain flavonoids in which the two 
aromatic rings are joined by a three-carbon 
unsaturated carbonyl system
Anti-inflammatory and antioxidant [46]
Chicoric acid Phenyl propanoid Amelioration of diabetes [47]
Chlorogenic acid and Caffeic acid Ameliorate glucose metabolism [48]





Lactucin Sesquiterpene lactones Antioxidative, Anti-inflammatory, and 
anti-hyperglycemic activities
[49]
Ferulic acid Phenolic compound In-vitro antioxidant activities, 
hypolipidemic properties, an in-vitro 




Anti-inflammatory activities in-vitro, 
inhibits cholesterol synthesis
[51]
Flavones Glycosides of luteolin and apigenin Weight loss, anti-atherogenic [52]
Flavonols Flavonoids Anti-inflammatory, anti-oxidant, and 
anti-proliferative effects, beneficial 
effects on endothelial function
[53]
Genistein and daidzein Isoflavones Suppress adipogenic differentiation of 
adipose tissue
[54]
Lignans Polyphenol Antioxidant and reduces total and LDL 
cholesterol
[55]
Luteolin Flavone Antioxidant and anti-inflammatory 
activities
[56]
Lycopene Red carotenoid Powerful antioxidant, inhibit of LDL 
oxidation and lipid peroxidation
[57]
Monoterpene Derivative auraptene PPARα/ƴ dual agonist, regulates the 
transcription of PPAR target genes, 
induces the expression of adiponectin, 
and inhibits those of MCP-1
[58]
Naringenin Flavanone Inhibits inflammation [59]
Allicin, allixin, and allyl sulphides Organosulfurs Decrease the synthesis of cholesterol 
by hepatocytes, lower blood pressure, 
powerful anti-thrombic, hypoglycemic
[60]
Campesterol, sitosterol, and 
stigmasterol 
Phytosterols Protect against atherosclerosis, 
decrease serum total and 
LDL-cholesterol levels, inhibit 
cholesterol absorption
[61]
Quercetin Flavonol Anti-lipase activity [62]
Resveratrol Stilbenoid Decrease LDL-cholesterol, exert 
anti-platelet
[63]
Sesquiterpenes Terpenes Anti-inflammatory, analgesic, and 
cytotoxic
[64]
Terpenoids (isoprenoids) Terpenes Activate PPARƴ, control energy 
homeostasis
[65]
LDL: Low-density lipoprotein, MCP-1: Monocyte chemoattractant protein-1, PPAR: Peroxisome proliferator-activated receptors
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efficacy. Moreover, all this comprehensive information such as 
indications, precautions, how to use the product, side effects, how to 
store the product, and regulatory information should accompany a 
leaflet that should be inserted into the product package. Recently in 
India, the Ministry of AYUSH has formulated the guidelines for licensing 
the herbal product (Ministry of AYUSH) [76]. However, more work is 
needed to be done for maintaining the quality and safety of herbal 
products. Many of the unregistered herbal products are sold freely in 
the market globally especially in developing countries with very little 
or no restraint. Further, the common belief is that natural products are 
not toxic and these drugs are routinely taking by the population. This 
needs to be cautioned. At the last, it has become essential that herbal 
products/medicines are put under the umbrella of drug regulatory 
framework in every country to maintain the drug standards of safety, 
quality, uniformity, and efficacy.
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